January 13, 2010 (Miami, Florida) — Aerosolized bronchodilators are independently associated with an increased risk for ventilator-associated pneumonia (VAP) in critically ill patients, according to ...

Patients with COPD also have a high prevalence of CVD. Bronchodilators prescribed for symptomatic COPD control may also contribute to cardiovascular risk. In accordance with treatment guidelines, most ...

And compared with the rest of the year, bronchodilator responsiveness was more common in winter months. HealthDay News — Patients are more likely to have positive bronchodilator responsiveness in the ...

A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life. The study ...

Please provide your email address to receive an email when new articles are posted on . Spirometry testing in the afternoon vs. morning was linked to a decreased likelihood for bronchodilator ...

Please provide your email address to receive an email when new articles are posted on . Bronchodilator responsiveness over 20% was linked to exacerbations and decreased prebronchodilator FEV 1. More ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

USA: Researchers have discovered in a new research that bronchodilator responsiveness (BDR) shows a stronger association with ...

August 16, 2010 — Nebulized hypertonic 3% saline solution without adjunctive bronchodilators has a low rate of adverse events in infants younger than 2 years with bronchiolitis, according to the ...

—Long-acting bronchodilators are recommended for initial maintenance of COPD. A new study compares the cardiovascular safety of 2 common treatment options. Reviewed by Ware Kuschner, MD, Professor of ...

A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease has been linked to a one-third higher risk of cardiovascular-related ...